2011 (2) TMI 1553

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....07. The assessment was framed by DCIT, Circle-8, Ahmedabad u/s143(3) r.w.s 147of the Income-tax Act, 1961 (hereinafter referred to as 'the Act') vide his order dated 29-12-2006. 2. The first issue in this appeal of Revenue is against the order of CIT(A) in directing the Assessing Officer to delete the disallowance out of garden expenses by treating such expenditure as rev expenditure u/s.37 of the Act. For this, Revenue has raised the following ground No.1:- "1. The ld. Commissioner of Income-tax(A)-XIV, Ahmedabad has erred in law and on facts in directing the Assessing Officer to delete the disallowance out of garden expenses Rs. 24,32,322/- by treating such expenditure as revenue expenditure u/s.37 of the Act." 3. At the....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

.... which affect the health of the workers. Thus, it is the duty of the assessee to make good the loss caused to nature and to prevent the health of thee workers engaged in production. Therefore, the assessee maintained the garden for maintaining better environment in the factory and the expenditure incurred in the process was therefore, for the purposes of the business of the assessee and was rightly allowed by the Learned Commissioner of Income Tax(Appeals). We therefore, confirm the order of the Learned Commissioner of Income Tax(Appeals) and dismiss the ground of appeal of the revenue." Respectfully following the same, we dismiss this issue in the appeal of Revenue. This issue of Revenue's appeal is dismissed.  4. The next issue in....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....gn country for the product which the assessee-company proposes to market in overseas market and without registration of the products, the assessee-company would not be able to market the products in the overseas market. Further, these payments are made to drug regulatory authorities in various countries for the products market in the respective countries. Furthermore, these fees are to be paid on recurring basis depending upon the validity of the various registrations. The fees have been paid on expiry of the registration and out of total payment of Rs. 28,14,355/- major payment of Rs. 8,03,706/- is in respect of product registration in Poland. Likewise payments have been made in Vietnam, Russia, Ghana and China etc. We find that the export....